Showing results (41-50 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Immunology|October 20, 2010
CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cellsMarija Vukicevic, Yves Chalandon, Claudine Helg, et al.
Blood|June 28, 2003
Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemiaXiaoyan Jiang, Matthew Stuible, Yves Chalandon, et al.
Journal of Fungi (Basel, Switzerland)|October 23, 2021
Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell TransplantationEmmanouil Glampedakis, Romain Roth, Stavroula Masouridi-Levrat, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2026
Does early letermovir initiation delay engraftment?Léna Royston, Catia Vieira Gomes, Ming Zou, et al.
Bulletin Du Cancer|November 28, 2017
[Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Nicolas Simon, Valérie Coiteux, Bénédicte Bruno, et al.
Frontiers in Immunology|June 4, 2019
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell TransplantationFederico Simonetta, Amandine Pradier, Carine Bosshard, et al.
Infection Control and Hospital Epidemiology|February 20, 2015
In-hospital transfer is a risk factor for invasive filamentous fungal infection among hospitalized patients with hematological malignancies: a matched case-control studyAngèle Gayet-Ageron, Anne Iten, Christian van Delden, et al.
Frontiers in Immunology|March 21, 2024
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case reportFederica Giannotti, Carmen De Ramon Ortiz, Federico Simonetta, et al.
Mycoses|July 11, 2022
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?Romain Samuel Roth, Stavroula Masouridi-Levrat, Federica Giannotti, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2026
Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenzaPauline Vetter, Ana Rita Goncalves Cabecinhas, Manuel Schibler, et al.
Pageof 22